Trevi Therapeutics, Inc.
Total Trades
49
Buys
9
Sells
22
Largest Trade
$1M+
Insiders
15
Institutional Funds
139
Inst. Value
$1M+
Activist Filings
48
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific O… | EXERCISE | $1K–$15K | 3K | $1.43 | Mar 26, 2025 |
| SCIASCIA THOMAS | Chief Scientific O… | SELL | $15K–$50K | 3K | $6.60 | Mar 26, 2025 |
| GOOD JENNIFER L | President & CEO | SELL | $15K–$50K | 5K | $6.58 | Mar 25, 2025 |
| GOOD JENNIFER L | President & CEO | EXERCISE | $1K–$15K | 5K | $1.43 | Mar 25, 2025 |
| Simon Farrell | Chief Commercial O… | SELL | $500K+ | 81K | $6.75 | Mar 12, 2025 |
| Simon Farrell | Chief Commercial O… | EXERCISE | $100K–$500K | 113K | $2.86 | Mar 12, 2025 |
| Meeker David P | Director | EXERCISE | $1K–$15K | 5K | $1.43 | Aug 29, 2024 |
| Meeker David P | Director | SELL | $1K–$15K | 5K | $2.93 | Aug 29, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | EXERCISE | $15K–$50K | 16K | $1.43 | Aug 21, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | SELL | $15K–$50K | 16K | $2.96 | Aug 21, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | EXERCISE | $15K–$50K | 32K | $1.43 | Aug 16, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | SELL | $50K–$100K | 32K | $2.77 | Aug 16, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | EXERCISE | $100K–$500K | 59K | $2.19 | May 31, 2024 |
| SCIASCIA THOMAS | Chief Scientific O… | SELL | $100K–$500K | 53K | $2.55 | May 31, 2024 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 4K | $2.64 | May 24, 2024 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 16K | $0.51 | May 24, 2024 |
| GOOD JENNIFER L | President & CEO | SELL | $50K–$100K | 25K | $2.86 | May 22, 2024 |
| GOOD JENNIFER L | President & CEO | EXERCISE | $50K–$100K | 25K | $2.19 | May 22, 2024 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 785 | $2.02 | Oct 12, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Oct 12, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 711 | $2.20 | Sep 13, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Sep 13, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Aug 14, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 682 | $2.36 | Aug 14, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 687 | $2.34 | Jul 12, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Jul 12, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 610 | $2.64 | Jun 14, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Jun 14, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 562 | $2.89 | May 15, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | May 15, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Apr 12, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 840 | $1.84 | Apr 12, 2023 |
| Delfini Lisa | CFO | SELL | $1K–$15K | 892 | $1.75 | Mar 15, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 2K | $0.51 | Mar 15, 2023 |
| Delfini Lisa | CFO | EXERCISE | $1K–$15K | 28K | $0.51 | Feb 15, 2023 |
| Delfini Lisa | CFO | SELL | $15K–$50K | 8K | $2.45 | Feb 15, 2023 |
| TPG GP A, LLC | Insider | SELL | $1M+ | 500K | $2.89 | Jul 6, 2022 |
| TPG GP A, LLC | 10% Owner | SELL | $1M+ | 476K | $2.77 | Jul 1, 2022 |
| TPG GP A, LLC | 10% Owner | SELL | $1K–$15K | 600 | $2.70 | May 4, 2022 |
| TPG GP A, LLC | 10% Owner | SELL | $50K–$100K | 23K | $2.75 | May 2, 2022 |
| Walker Paul Edward | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| Sonsini Peter W. | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| SANDELL SCOTT D | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| Makhzoumi Mohamad | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| Florence Anthony A. Jr. | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| Chang Carmen | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| Behbahani Ali | 10% Owner | BUY | $1M+ | 3.6M | $1.90 | Apr 13, 2022 |
| BASKETT FOREST | 10% Owner | BUY | $1M+ | 2.6M | $1.90 | Apr 13, 2022 |
| New Enterprise Associates 16, L.P. | 10% Owner | BUY | $1M+ | 2.6M | $1.90 | Apr 13, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 139 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| NEA Management Company, LLC | 13.2M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 10.3M | $1M+ | SH |
| VANGUARD GROUP INC | 5.6M | $1M+ | SH |
| Vivo Capital, LLC | 5.1M | $1M+ | SH |
| Rubric Capital Management LP | 3.8M | $1M+ | SH |
| MPM BioImpact LLC | 3.3M | $1M+ | SH |
| VIKING GLOBAL INVESTORS LP | 3.2M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 3.2M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 3.1M | $1M+ | SH |
| Octagon Capital Advisors LP | 2.8M | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.6M | $1M+ | SH |
| STATE STREET CORP | 2.4M | $1M+ | SH |
| Siren, L.L.C. | 2.3M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $1M+ | SH |
| Artia Global Partners LP | 2.0M | $1M+ | SH |
| EMERALD ADVISERS, LLC | 1.9M | $1M+ | SH |
| Logos Global Management LP | 1.6M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.5M | $1M+ | SH |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1.3M | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
2.9%
3.8M shares
New Enterprise Associates 16, L.P.
SC 13D/A · Feb 13, 2026
11.6%
15.1M shares
SC 13G · Feb 5, 2026
5.1%
6.5M shares
SC 13G · Jan 30, 2026
5.0%
6.4M shares
SC 13G/A · Nov 14, 2025
4.2%
5.1M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Nov 14, 2025
7.0%
8.5M shares
SC 13G · Oct 17, 2025
5.6%
6.8M shares
SC 13G/A · Aug 14, 2025
5.9%
7.5M shares
New Enterprise Associates 16, L.P.
SC 13D/A · Aug 11, 2025
12.0%
15.1M shares
SC 13G · Jul 9, 2025
7.1%
8.5M shares
SC 13G/A · May 15, 2025
8.7%
9.2M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · May 15, 2025
8.8%
8.5M shares
New Enterprise Associates 16, L.P.
SC 13D/A · Mar 20, 2025
15.0%
15.1M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 14, 2025
1.4%
1.3M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Feb 14, 2025
9.9%
8.8M shares
SC 13G/A · Feb 13, 2025
4.7%
4.2M shares
SC 13G/A · Feb 13, 2025
1.2%
1.1M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Nov 14, 2024
10.0%
7.7M shares
SC 13G/A · Nov 13, 2024
6.9%
5.0M shares
New Enterprise Associates 16, L.P.
SC 13D/A · Nov 8, 2024
18.7%
15.1M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13G/A · Nov 6, 2024
7.8%
5.6M shares
SC 13G/A · Oct 23, 2024
1.0%
750K shares
SC 13G/A · Jul 11, 2024
2.0%
1.4M shares
SC 13G/A · Jul 10, 2024
2.2%
1.5M shares
New Enterprise Associates 16, L.P.
SC 13D/A · May 21, 2024
20.3%
15.1M shares
SC 13G/A · Apr 25, 2024
1.3%
926K shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 15, 2024
10.0%
6.7M shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
10.0%
6.6M shares
SC 13G/A · Feb 12, 2024
8.9%
5.7M shares
SC 13G · Feb 15, 2023
4.2%
2.5M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 14, 2023
10.0%
6.3M shares
Fairmount Funds Management LLC
SC 13G/A · Feb 14, 2023
9.9%
6.0M shares
SC 13G/A · Feb 14, 2023
5.0%
3.1M shares
SC 13G/A · Feb 14, 2023
10.0%
6.2M shares
SC 13G/A · Feb 10, 2023
0.0%
0 shares
SC 13G · Feb 10, 2023
9.5%
5.7M shares
SC 13G · Oct 7, 2022
10.0%
6.0M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Oct 7, 2022
8.7%
5.1M shares
New Enterprise Associates 16, L.P.
SC 13D/A · Apr 25, 2022
42.5%
14.4M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G · Apr 21, 2022
10.0%
3.7M shares
Fairmount Funds Management LLC
SC 13G · Apr 21, 2022
9.9%
3.8M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · Apr 18, 2022
7.0%
2.6M shares
SC 13G · Mar 9, 2022
8.5%
2.2M shares
SC 13G · Mar 9, 2022
1.4%
360K shares
SC 13G · Feb 14, 2022
10.0%
2.7M shares
SC 13G/A · Feb 11, 2022
18.7%
4.8M shares
Lundbeckfond Invest A/S (“Lundbeckfond”)
SC 13G/A · Jan 26, 2022
4.5%
1.2M shares